|
 |
|
|
|
CAS No.: 83150-76-9 Formula: C49H66N10O10S2
Weight: 1019.24000
Synonyms: ctreotide; OCTREOTIDE ACETATE (GMP); H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol acetate salt (Disulfide bond); DARAMONOL; Phe-c(Cys-Phe-Trp-Lys-Thr-Cys)-CH(CH2OH)-CH(OH)-CH3; D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-N-[(1R,2R)-1-(Hydroxymethyl)-2-hydroxypropyl]-NH2; Octreotode Acetate; Longastatin; Octreotideacetate; Sandostatin<*>; OXTREOTIDE; Ocetreotide,Acetate;
Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.
